Expectations trend
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsNASDAQFinancialsInsurance - Property & CasualtySnapshot 2026-11-05
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for NODK yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
stable leadership and execution | A supporting condition in NI Holdings, Inc.'s published investment case. The stated target is no further CEO or key director departures. | Intact | CEO or key director departures occur | 0 CEO departures vs 0 allowed News shows only routine earnings and a planned director transition; no executive departures triggering the trip condition. Nov 5, 2026Last status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Oct 7–Nov 5 · 0 recorded
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 6, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earningsObserved price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is an insurance turnaround and execution story, not yet a steady compounder. The long-term thesis is in a watch state: management is narrowing focus toward core insurance segments, while recent financial performance remains weak relative to its industry cohort.
The valuation evidence points to NODK being cheap versus peers, with a moderate expectations gap. That discount sits alongside a loss-making value profile, but the snapshot says pricing fragility is low and is not concentrated across multiple risk factors.
Near term, premiums may remain pressured as the company exits Non-Standard Auto, even as that move supports a more focused underwriting approach. Combined ratios improved year over year in both reported quarters, helped by favorable reserve development and lower losses, but recent performance is still weak and risk is elevated.
Over the next one to three years, the thesis depends on whether underwriting improvements can persist while NODK focuses on its core segments. Near-term sector signals also matter: continued strength from CB, PGR, and TRV could support the Financials backdrop, while weaker results or guidance could remove that support; rate cuts from the current 3.88% are another stated risk.
NODK has signs of improving execution, but the multi-year view remains uncertain because recent performance is weak and the valuation discount does not resolve the operating risks. The thesis hinges on sustained underwriting progress and a supportive sector backdrop. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| A primary condition in NI Holdings, Inc.'s published investment case. The stated target is free cash flow yield improves toward 0% or positive. |
| Broken |
| free cash flow yield remains below -8% or worsens |
Free cash flow yield: -10.22% As of 2026-11-05; trailing twelve months. The target timing and basis require a separate assessment. Nov 5, 2026-10.22 percent · calculatedLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
revenue decline limited to no worse than -13% next year | Analysts expect revenue to decline about 13% next year, reflecting challenges but also potential for recovery. | Intact | YoY revenue growth falls below -13% next year | Revenue growth: -7.66% FY2026-Q2; GAAP. Published target: >= -13% YoY revenue growth. Reported actuals cannot certify a consensus target without an explicit period and accounting-basis binding. Aug 7, 2026-7.6561 percent · calculatedLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 7, 2026–Nov 5, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
2 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.